American Journal of Internal Medicine

Volume 10, Issue 6, November 2022

  • Illicit Use of Gabapentin May Reveal More About the Drug’s Benefits Than Its Liabilities

    Michael Raymond Binder

    Issue: Volume 10, Issue 6, November 2022
    Pages: 114-121
    Received: 17 October 2022
    Accepted: 2 November 2022
    Published: 10 November 2022
    DOI: 10.11648/j.ajim.20221006.11
    Abstract: The anticonvulsant gabapentin is now one of the most commonly prescribed drugs in America. However, after nearly three decades of steady growth in popularity, the drug is becoming as controversial as it is popular. Although gabapentin was initially approved for the adjunctive treatment of partial seizures, its use has gradually expanded to an ever-... Show More